Shaun D. McMeans
2020
In 2020, Shaun D. McMeans earned a total compensation of $803.8K as Senior Vice President and Chief Financial Officer at HTG Molecular Diagnostics, a 119% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $48,330 |
|---|---|
| Option Awards | $396,744 |
| Salary | $358,000 |
| Other | $741 |
| Total | $803,815 |
McMeans received $396.7K in option awards, accounting for 49% of the total pay in 2020.
McMeans also received $48.3K in non-equity incentive plan, $358K in salary and $741 in other compensation.
Rankings
In 2020, Shaun D. McMeans' compensation ranked 9,487th out of 13,090 executives tracked by ExecPay. In other words, McMeans earned more than 27.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 9,487 out of 13,090 | 28th |
Division Manufacturing | 4,064 out of 5,620 | 28th |
Major group Measuring, Analyzing, And Controlling Instruments; Photographic, Medical And Optical Goods; Watches And Clocks | 521 out of 799 | 35th |
Industry group Laboratory Apparatus And Analytical, Optical, Measuring, and Controlling Instruments | 149 out of 227 | 34th |
Industry Laboratory Analytical Instruments | 57 out of 82 | 31st |
Source: SEC filing on July 7, 2022.
McMeans' colleagues
We found two more compensation records of executives who worked with Shaun D. McMeans at HTG Molecular Diagnostics in 2020.